Machine learning model predicts poor pain-related quality of life after endometriosis surgery to assist clinicians with preoperative counseling.
Nektar Therapeutics, and we continue to build on the success with significant progress in 2026. In October 2023, we began the ...
Barclays 28th Annual Global Healthcare Conference March 11, 2026 10:30 AM EDTCompany ParticipantsSanjiv Patel - ...
Late in 2023, the corporate world was abuzz with the utopian promise of AI — especially about the tech’s effects on the environment. So far, reality has demonstrated the exact opposite. Not only are ...
Nektar Therapeutics (NASDAQ:NKTR) Q4 2025 Earnings Call Transcript March 12, 2026 Nektar Therapeutics beats earnings expectations. Reported EPS is $-1.77756, expectations were $-2.47411. Operator: ...
Virtue SAB agreement with Terumo that was announced in October 2025 NEW HOPE, Pa., March 12, 2026 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) (“Orchestra BioMed” or the “Company ...
December 31, 2025 to be further enhanced by $35 million expected from Medtronic and Ligand in Q2 2026 from previously announced transactions, as well as Haemonetics' ...
Miracle Trial Preliminary Blinded CRc Rate of 40% in First 30 Patients Suggests Encouraging Early Results in Relapsed/Refractory AML HOUSTON, March 19, 2026 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc.
Morning Overview on MSN
Trial: Sulthiame pill cut sleep apnea breathing interruptions by 50%
A once-daily pill called sulthiame cut breathing interruptions during sleep by up to 47 percent in adults with obstructive ...
Background The presence of a coincident intracranial aneurysm (CIA) on the target vessel of patients undergoing mechanical thrombectomy (MT) for acute ischemic stroke (AIS) poses challenges, as the ...
Background General practitioners (GPs) less often prescribe treatments for smoking cessation than for other major risk factors. We assessed the effect of training GPs to offer smoking cessation ...
Miracle Trial Preliminary Blinded CRc Rate of 40% in First 30 Patients Suggests Encouraging Early Results in Relapsed/Refractory AMLHOUSTON, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results